(Q80605580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

main subject

phase II clinical trial

1 reference

1 reference

Rachel P Riechelmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Carol A Townsley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sheray N Chin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gregory R Pond

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jennifer J Knox

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1307-1312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Worldwide trends in mortality from biliary tract malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Gallbladder cancer, a different disease that needs individual trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Phase II study of erlotinib in patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

A phase II study of gemcitabine in gallbladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22902

7 January 2021

Identifiers

DOI

10.1002/CNCR.22902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17628484%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference